Cargando…
AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm
Is it possible to develop a reliable, safe treatment for the widespread COVID-19 pandemic shortly? COVID-19 is characterized by a disruptive cytokine storm, quickly and often irreversibly damaging the patient’s lungs, as its main target organ, leading to lung failure and death. Actual experimental t...
Autores principales: | Gangemi, Sebastiano, Tonacci, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480641/ https://www.ncbi.nlm.nih.gov/pubmed/32938545 http://dx.doi.org/10.1016/j.cytogfr.2020.09.001 |
Ejemplares similares
-
Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models
por: Murdaca, Giuseppe, et al.
Publicado: (2019) -
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2020) -
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia
por: Dereani, Sara, et al.
Publicado: (2014) -
Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis
por: Wang, Jianguo, et al.
Publicado: (2020) -
AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism
por: Rech, Monika, et al.
Publicado: (2018)